Today (11th), the National Health Insurance Administration held a regular press conference for the first half of 2024. Centralized pharmaceutical procurement has been implemented for 5 years. At today's press conference, relevant officials said that more than 1,600 products have been selected from the 9 batches of nationally organized drug collection that has now been carried out, with generic drugs made in China accounting for 96%. The domestic drug usage pattern is gradually returning to international experience and the value rules of drugs themselves, which ultimately benefits the public. (CCTV News)
国家医保局：9批国家组织药品集采国产仿制药占96%
National Health Insurance Administration: Nine batches of state-organized drugs collected domestically produced generic drugs, accounting for 96%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.